1. One-Week Kava Dietary Supplementation Increases Both Urinary N - and O -Glucuronides of NNAL, a Lung Carcinogen Major Metabolite, among Smokers.
- Author
-
Hu Q, Tang Z, Lynch A, Freeman B, Fujioka N, Salloum RG, Malaty J, Orlando FA, Langaee T, Huo Z, and Xing C
- Subjects
- Humans, Male, Female, Lung Neoplasms chemically induced, Middle Aged, Pyridines urine, Pyridines chemistry, Pyridines administration & dosage, Smoking urine, Smokers, Glucuronosyltransferase metabolism, Glucuronosyltransferase genetics, Adult, Polymorphism, Single Nucleotide, Kava chemistry, Nitrosamines urine, Nitrosamines metabolism, Carcinogens metabolism, Glucuronides urine, Dietary Supplements
- Abstract
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (commonly known as NNK) is one of the most prevalent and potent pulmonary carcinogens in tobacco products that increases the human lung cancer risk. Kava has the potential to reduce NNK and tobacco smoke-induced lung cancer risk by enhancing urinary excretion of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL, the major metabolite of NNK) and thus reducing NNK-induced DNA damage. In this study, we quantified N -glucuronidated NNAL (NNAL- N -gluc), O -glucuronidated NNAL (NNAL- O -gluc), and free NNAL in the urine samples collected before and after 1-week kava dietary supplementation. The results showed that kava increased both NNAL-N-glucuronidation and O-glucuronidation. Since NNAL-N-glucuronidation is dominantly catalyzed by UGT2B10, its representative single-nucleotide polymorphisms (SNPs) were analyzed among the clinical trial participants. Individuals with any of the four analyzed SNPs appear to have a reduced basal capacity in NNAL-N-glucuronidation. Among these individuals, kava also resulted in a smaller extent of increases in NNAL-N-glucuronidation, suggesting that participants with those UGT 2 B 10 SNPs may not benefit as much from kava with respect to enhancing NNAL-N-glucuronidation. In summary, our results provide further evidence that kava enhances NNAL urinary detoxification via an increase in both N-glucuronidation and O-glucuronidation. UGT2B10 genetic status has not only the potential to predict the basal capacity of the participants in NNAL-N-glucuronidation but also potentially the extent of kava benefits.
- Published
- 2024
- Full Text
- View/download PDF